Clinical Trials Logo

Clinical Trial Summary

Chronic leg ulcerations are a great burden for patients and the medical system alike. Frequent outpatient consultations with associated treatment costs and travel costs for the patient as well as psychosocial burdens remain an unmet problem in chronic wound care. There is an increasing need for definitive treatment of especially chronic venous and multifactorial chronic leg ulceration where arterial intervention is not a treatment option. Minimal invasive surgical interventions that do not require skin grafting can be performed under local anesthesia in an outpatient setting even in multimorbid patients. Kerecis Omega3 Wound is intact decellularized fish skin. The fish skin sheets contain fat, protein, elastin, glycans and other natural skin elements and it can be an effective treatment option in chronic leg ulcerations and is licensed for this use as a medical product in Switzerland. However, limited data without inter-wound bias is available for the use of Kerecis Omega 3 in chronic leg ulcerations. In this study the investigators propose to investigate the efficacy of Kerecis Omega 3 according to objective wound surface measurements using standardized digital photographs in patients with chronic leg ulcerations. Efficacy will be evaluated against standard of care wound debridement.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06036485
Study type Interventional
Source Insel Gruppe AG, University Hospital Bern
Contact
Status Withdrawn
Phase N/A
Start date May 1, 2023
Completion date May 1, 2023

See also
  Status Clinical Trial Phase
Completed NCT03644849 - Evaluating the Safety and Efficacy of Fractionated Carbon Dioxide Therapy in Postoperative Lower Extremity Wound Healing N/A
Recruiting NCT02842502 - Clinical Feasibility of an Advanced Therapy Medicinal Product (ATMP) Preparation for Autologous Skin Regeneration in Case of Chronic Leg Ulcers N/A
Active, not recruiting NCT01903044 - Safety and Efficacy of Autologous Bone Marrow Stem Cells for Lower Extremity Ischemia Treating Phase 1/Phase 2
Terminated NCT01966380 - Proof of Concept (Design Validation) in Patient With Hard to Heal Wounds Such as Pressure Ulcer, Diabetic Foot Ulcer and Leg Ulcer, Leia Phase 2
Terminated NCT02509533 - Comparison of the Use of VAC System in Transplants of Leg Ulcers Versus Usual Dressing Method N/A
Completed NCT00371371 - Intra-arterial Stem Cell Therapy for Patients With Chronic Limb Ischemia (CLI) Phase 1/Phase 2
Active, not recruiting NCT00270972 - The Evaluation of OrCel for the Treatment of Venous Ulcers N/A
Terminated NCT01657318 - Olivamine-containing Products in the Management of Patients With Nonhealing Lower Extremity Ulcers
Completed NCT02392390 - Effects of Topical Dynamic Phototherapy on the Microbiota of Chronic Wounds N/A
Not yet recruiting NCT06007703 - Evaluation of the Efficacy of Multilayer Compression & UrgoStart Plus
Recruiting NCT02987101 - Treatment of Chronic Leg Ulcers With Autologous Stromal Vascular Fraction N/A
Active, not recruiting NCT02973893 - Study of VF001-DP in Patients With Chronic Venous Leg Ulcers Phase 2
Not yet recruiting NCT02873728 - Remote Ischemic Conditioning for Treatment of Chronic Wounds N/A
Completed NCT01551667 - Immune Response of Patients With Chronic, Staphylococcus Aureus-infected Wounds N/A
Completed NCT01497210 - EASH Dressing on Chronic Venous Leg Ulcers Phase 2
Completed NCT00235209 - A Study to Evaluate the Clinical Effectiveness of a Collagen-ORC Antimicrobial Matrix in Venous Leg Ulcers Phase 4
Not yet recruiting NCT06153589 - Effectiveness of Musicotherapy in Reducing Pain Induced by Leg Ulcer Care N/A
Completed NCT01591434 - Study to Evaluate the Performance of AQUACEL® Extraâ„¢ in Venous Leg Ulcers Phase 3
Completed NCT00838500 - THERMES ET VEINES: Spa for Prevention of Leg Ulcers Phase 3
Completed NCT00243620 - A Randomised Controlled Trial Comparing Vacuum Assisted Closure (V.A.C.®) With Modern Wound Dressings N/A